David Schaack, Boris Schmidt, Shota Tohoku, Stefano Bordignon, Lukas Urbanek, Ramin Ebrahimi, Jun Hirokami, Tolga Han Efe, Shaojie Chen, Kr Julian Chun
{"title":"Pulsed Field Ablation for Atrial Fibrillation.","authors":"David Schaack, Boris Schmidt, Shota Tohoku, Stefano Bordignon, Lukas Urbanek, Ramin Ebrahimi, Jun Hirokami, Tolga Han Efe, Shaojie Chen, Kr Julian Chun","doi":"10.15420/aer.2022.45","DOIUrl":null,"url":null,"abstract":"<p><p>Catheter ablation is a widely used, effective and safe treatment for AF. Pulsed field ablation (PFA), as a novel energy source for cardiac ablation, has been shown to be tissue selective and is expected to decrease damage to non-cardiac tissue while providing high efficacy in pulmonary vein isolation. The FARAPULSE ablation system (Boston Scientific) follows the idea of single-shot ablation and is the first device approved for clinical use in Europe. Since its approval, multiple high-volume centres have performed increasing numbers of PFA procedures in patients with AF and have published their experiences. This review summarises the current clinical experience regarding the use of PFA for AF using the FARAPULSE system. It provides an overview of its efficacy and safety.</p>","PeriodicalId":8412,"journal":{"name":"Arrhythmia & Electrophysiology Review","volume":"12 ","pages":"e11"},"PeriodicalIF":2.6000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/ca/d0/aer-12-e11.PMC10326665.pdf","citationCount":"4","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Arrhythmia & Electrophysiology Review","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.15420/aer.2022.45","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 4
Abstract
Catheter ablation is a widely used, effective and safe treatment for AF. Pulsed field ablation (PFA), as a novel energy source for cardiac ablation, has been shown to be tissue selective and is expected to decrease damage to non-cardiac tissue while providing high efficacy in pulmonary vein isolation. The FARAPULSE ablation system (Boston Scientific) follows the idea of single-shot ablation and is the first device approved for clinical use in Europe. Since its approval, multiple high-volume centres have performed increasing numbers of PFA procedures in patients with AF and have published their experiences. This review summarises the current clinical experience regarding the use of PFA for AF using the FARAPULSE system. It provides an overview of its efficacy and safety.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
